NCT03111966View on ClinicalTrials.gov

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

November 30, 2017

Conditions
Hepatitis C
Interventions
OTHER

Spanish cohort with HCV treated in real practice with Elbasvir/Grazoprevir

Spanish cohort with HCV treated in real practice with Elbasvir/Grazoprevir

Trial Locations (1)

28020

HepaC, Madrid

All Listed Sponsors
lead

Hepa C

OTHER

NCT03111966 - Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort | Biotech Hunter | Biotech Hunter